BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Glenda joined Pappas Capital in September 2018 as Executive Administrative Assistant. She has over 20 years of experience utilizing strong problem solving and organization skills to support operational and administrative functions in the pharmaceutical and technology industries. Prior to joining Pappas Capital, Glenda worked at Greenwich Biosciences supporting the Vice President of Clinical Sciences and US Regulatory teams, and managing the RTP office. Glenda has also supported executive leadership at Pfizer, King Pharmaceuticals and Cisco Systems.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.